Population pharmacokinetics of arbekacin in burn patientsJONG HYUN KIM; LAH, Hyon-Oh; YIM, Dong-Seok et al.European journal of clinical pharmacology. 2008, Vol 64, Num 6, pp 599-603, issn 0031-6970, 5 p.Article

Population pharmacokinetic modelling of BIBN 4096 BS, the first compound of the new class of calcitonin gene-related peptide receptor antagonistsTROCONIZ, Inaki F; WOLTERS, Jan-Markus; SCHAEFER, Hans Guenter et al.European journal of pharmaceutical sciences. 2004, Vol 22, Num 4, pp 287-295, issn 0928-0987, 9 p.Article

Population pharmacokinetics of itraconazole solution used as prophylaxis for febrile neutropeniaKANBAYASHI, Yuko; NOMURA, Kenichi; TANIWAKI, Masafumi et al.International journal of antimicrobial agents. 2008, Vol 31, Num 5, pp 452-457, issn 0924-8579, 6 p.Article

Population pharmacokinetic study of methotrexate in patients with lymphoid malignancyFALTAOS, Demiana William; HULOT, Jean Sebastian; URIEN, Saïk et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 5, pp 626-633, issn 0344-5704, 8 p.Article

Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine^®) in cancer patientsKOLESAR, Jill; BRUNDAGE, Richard C; POMPLUN, Marcia et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 2, pp 393-400, issn 0344-5704, 8 p.Article

Population Pharmacokinetic Analysis during the First 2 Years of Life: An OverviewMARSOT, Amélie; BOULAMERY, Audrey; BRUGUEROLLE, Bernard et al.Clinical pharmacokinetics. 2012, Vol 51, Num 12, pp 787-798, issn 0312-5963, 12 p.Article

Reporting a Population Pharmacokinetic-Pharmacodynamic Study: A Journal's PerspectiveJAMSEN, Kris M; McLEAY, Sarah C; BARRAS, Michael A et al.Clinical pharmacokinetics. 2014, Vol 53, Num 2, pp 111-122, issn 0312-5963, 12 p.Article

Some considerations on the design of population pharmacokinetic studiesDUFFULL, Stephen; WATERHOUSE, Tim; ECCLESTON, John et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2005, Vol 32, Num 3-4, pp 441-457, issn 1567-567X, 17 p.Article

Population Pharmacokinetic Meta-Analysis of Vortioxetine in Healthy IndividualsAREBERG, Johan; PETERSEN, Kamilla B; CHEN, Grace et al.Basic & clinical pharmacology & toxicology (Print). 2014, Vol 115, Num 6, pp 552-559, issn 1742-7835, 8 p.Article

Fundamentals of Population Pharmacokinetic Modelling: Validation MethodsSHERWIN, Catherine M. T; KIANG, Tony K. L; SPIGARELLI, Michael G et al.Clinical pharmacokinetics. 2012, Vol 51, Num 9, pp 573-590, issn 0312-5963, 18 p.Article

Methods to Account for Inaccuracies in the Dosing History When Performing Population Pharmacokinetic AnalysisPAVAN KUMAR, Venkata V; DUFFULL, Stephen B.Pharmaceutical research. 2008, Vol 25, Num 12, pp 2740-2749, issn 0724-8741, 10 p.Article

Population pharmacokinetics of troxacitabine, a novel dioxolane nucleoside analogueLEE, Carlton K. K; ROWINSKY, Eric K; JING LI et al.Clinical cancer research. 2006, Vol 12, Num 7, pp 2158-2165, issn 1078-0432, 8 p., 1Article

The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/pharmacodynamic analysesVRIJENS, Bernard; GROSS, Robert; URQUHART, John et al.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 96, Num 3, pp 225-227, issn 1742-7835, 3 p.Article

Edoxaban population pharmacokinetics and exposure-response analysis in patients with non-valvular atrial fibrillationYIN, Ophelia Q. P; TETSUYA, Kimura; MILLER, Raymond et al.European journal of clinical pharmacology. 2014, Vol 70, Num 11, pp 1339-1351, issn 0031-6970, 13 p.Article

Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitusBARDIN, Christophe; NOBECOURT, Estelle; LARGER, Etienne et al.European journal of clinical pharmacology. 2012, Vol 68, Num 6, pp 961-968, issn 0031-6970, 8 p.Article

Population pharmacokinetics and pharmacogenetics of vincristine in paediatric patients treated for solid tumour diseasesGUILHAUMOU, Romain; SIMON, Nicolas; QUARANTA, Sylvie et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 5, pp 1191-1198, issn 0344-5704, 8 p.Article

Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patientsLATZ, Jane E; CHAUDHARY, Ajai; GHOSH, Atalanta et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 4, pp 401-411, issn 0344-5704, 11 p.Article

Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgeryISLA, Arantxazu; TROCONIZ, Iñaki F; DE TEJADA, Ignacio López et al.European journal of clinical pharmacology. 2012, Vol 68, Num 5, pp 735-745, issn 0031-6970, 11 p.Article

Significance of individual adjustment of initial loading dosage of teicoplanin based on population pharmacokineticsNIWA, Takashi; IMANISHI, Yoshinori; OHMORI, Tomofumi et al.International journal of antimicrobial agents (Print). 2010, Vol 35, Num 5, pp 507-510, issn 0924-8579, 4 p.Article

Modelling ocular pharmacokinetics of fluorescein administered as lyophilisate or conventional eye dropsABDULJALIL, Khaled; DIESTELHORST, Michael; DOROSHYENKO, Oxana et al.European journal of clinical pharmacology. 2008, Vol 64, Num 5, pp 521-529, issn 0031-6970, 9 p.Article

Individualising netilmicin dosing in neonatesSHERWIN, Catherine M. T; BROADBENT, Roland S; MEDLICOTT, Natalie J et al.European journal of clinical pharmacology. 2008, Vol 64, Num 12, pp 1201-1208, issn 0031-6970, 8 p.Article

Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parametersCOMETS, Emmanuelle; VERSTUYFT, Celine; LAVIELLE, Marc et al.European journal of clinical pharmacology. 2007, Vol 63, Num 5, pp 437-449, issn 0031-6970, 13 p.Article

Population pharmacokinetics of mefloquine in military personnel for prophylaxis against malaria infection during field deploymentCHARLES, B. G; BLOMGREN, A; NASVELD, P. E et al.European journal of clinical pharmacology. 2007, Vol 63, Num 3, pp 271-278, issn 0031-6970, 8 p.Article

Clinical pharmacokinetics of bevacizumab in patients with solid tumorsLU, Jian-Feng; BRUNO, Rene; EPPLER, Steve et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 5, pp 779-786, issn 0344-5704, 8 p.Article

Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomitingNAKADE, Susumu; OHNO, Tomoya; KITAGAWA, Junsaku et al.Cancer chemotherapy and pharmacology. 2008, Vol 63, Num 1, pp 75-83, issn 0344-5704, 9 p.Article